Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles | Zendy

Se Ryeong Jang | Zendy; Han Truong | Zendy; Aaron Oh | Zendy; Jin Choi | Zendy; Angela C. Tramontano | Zendy; Monika Laszkowska | Zendy; Chin Hur | Zendy

Open Access

Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles

Author(s) -

Se Ryeong Jang,

Han Truong,

Aaron Oh,

Jin Choi,

Angela C. Tramontano,

Monika Laszkowska,

Chin Hur

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.19963

Subject(s) - medicine , kras , colorectal cancer , biomarker , oncology , reimbursement , colectomy , quality adjusted life year , cost effectiveness , cancer , health care , biochemistry , chemistry , risk analysis (engineering) , economics , economic growth

This economic evaluation study assesses the cost-effectiveness of 3 therapeutic strategies (endoscopic therapy, laparoscopic colectomy, and open colectomy) for patients with T1 colorectal cancer with biomarker profiles that predict varying levels of tumor progression in the US payer perspective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research